Effects of Flumazenil on Recovery After Total Intravenous Anesthesia With Remimazolam
Status:
Recruiting
Trial end date:
2024-06-01
Target enrollment:
Participant gender:
Summary
Remimazolam is a medication that has the advantage of a short half-life and reversibility
with flumazenil. In clinical situations, the use of flumazenil for the reversal of sedation
is common, but there is no precise indication for its administration. In this study, we aim
to investigate the necessity of routine flumazenil use after administering remimazolam for
intravenous anesthesia.